Ocugen, Inc.
Overview
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing transformative therapies to address rare and underserved eye diseases. The company is committed to harnessing innovative technologies to develop novel solutions for patients.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Ocugen, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.